Standard view: FDA bureaucrats are overly cautious because visible Type I errors (approved drugs that harm) draw political blame while invisible Type II errors (unapproved drugs that would have helped) do not, creating a natural bias toward caution.

causalpending

Speaker

Russ Roberts

Evidence Quote

“The harm is visible, and they'll pay a political price for it, whereas the other type of error of not allowing a drug... we don't see the harm as much”

Source

Richard Epstein on Property Rights and Drug Patents 2/19/2007— EconTalk
Created: 10/30/2026, 3:22:16 PM

Your notes

Loading notes...